New route to target RAS
- PMID: 38730259
- DOI: 10.1038/d41573-024-00082-8
New route to target RAS
Keywords: Cancer; Chemistry; Drug discovery; Medical research.
Comment on
-
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.Nature. 2024 May;629(8013):919-926. doi: 10.1038/s41586-024-07205-6. Epub 2024 Apr 8. Nature. 2024. PMID: 38589574 Free PMC article.
References
-
- Holderfield, M. et al. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy. Nature https://doi.org/10.1038/s41586-024-07205-6 (2024)
-
- Wasko, U. N. et al. Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature https://doi.org/10.1038/s41586-024-07379-z (2024)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources